Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin pharmacogenetic study of SLC22A1 and ATM polymorphisms in type 2 diabetes
ChiCTR1900026423Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: genotype, blood glucose and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900026423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026423.